chr2-32063962-C-T

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACGS-UK Somatic Oncogenicity v2025).

The NM_014946.4(SPAST):c.131C>T (p.Ser44Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00785 (AC=12,656) in the gnomAD database across 1,612,216 control chromosomes, including 71 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.00981. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S44= (synonymous): Likely_benign (ClinVar VariationId 2168183, 1 star) The variant has been observed in cBioPortal in 2 samples across 2 studies and 1 cancer type; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.0050 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0081 ( 65 hom. )

Consequence

SPAST
NM_014946.4 missense

Scores

4
8
7

Clinical Significance

Benign/Likely benign; other; risk factor criteria provided, multiple submitters, no conflicts B:15O:4

Conservation

PhyloP100: 5.07

Publications

39 publications found
Variant links:
Genes affected
SPAST (HGNC:11233): (spastin) This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018]
SPAST Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Genomics England PanelApp
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • SPAST-related motor disorder
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014946.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

No applied criteria
Uncheck "Show applied only" above to review all 20 criteria.

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_014946.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

SPAST NM_014946.4
MANE Select
HGVSc / HGVSpc.131C>Tp.Ser44Leu
Exon rankExon 1 of 17
missense
Prot: NP_055761.2
SPAST NM_001363823.2
HGVSc / HGVSpc.131C>Tp.Ser44Leu
Exon rankExon 1 of 17
missense
Prot: NP_001350752.1UniProt: A0A2U3TZR0
SPAST NM_199436.2
HGVSc / HGVSpc.131C>Tp.Ser44Leu
Exon rankExon 1 of 16
missense
Prot: NP_955468.1UniProt: E5KRP6Q9UBP0-2

Ensembl Transcripts

SPAST ENST00000315285.9
TSL:1MANE Select
HGVSc / HGVSpc.131C>Tp.Ser44Leu
Exon rankExon 1 of 17
missense
Prot: ENSP00000320885.3UniProt: Q9UBP0-1
SPAST ENST00000621856.2
TSL:1
HGVSc / HGVSpc.131C>Tp.Ser44Leu
Exon rankExon 1 of 17
missense
Prot: ENSP00000482496.2UniProt: A0A2U3TZR0
SPAST ENST00000713716.1
HGVSc / HGVSpc.131C>Tp.Ser44Leu
Exon rankExon 1 of 18
missense
Prot: ENSP00000519019.1UniProt: A0AAQ5BGQ0

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00500
AC:761
Hom:6
AN:152164
Cov:32
GnomAD2 exomes
AF: 0.00456
AC:1116
AN:244870
GnomAD4 exome
AF: 0.00815
AC:11895
Hom:65
AN:1459944
Cov:35
GnomAD4 genome
AF: 0.00500
AC:761
Hom:6
AN:152272
Cov:32
TOPMed (Bravo)
AF: 0.00463
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00704
AC:2370
Hom:13
AN:336450
Local & regional cohorts 7 sources
ABraOM SABE-WGS-1171
AF: 0.00427
AC:10
Hom:0
AN:2342
ChinaMAP Phase 1
AF: 0.000197
Denmark Genome
AF: 0.0167
AC:5
AN:300
ESP6500 (Exome Variant Server)
AF: 0.00654
AC:85
AN:13002
GenomeAsia100K
AF: 0.00174
AC:6
AN:3470
Turkish Variome
AF: 0.000923
AC:5
Hom:0
AN:4942
UK10K
AF: 0.0110
AC:83
AN:7562
Showing 13 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.00876 *9711070 0.00899 *15817568
BipEx
(Bipolar disorder (including schizoaffective))
0.00943 26828414 0.00947 27328840
Epi25
(Epilepsy)
0.00663 27841934 0.00698 46766882
SCHEMA
(Schizophrenia)
0.00443 540121854 0.00519 991190806
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign/Likely benign; other; risk factor
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Hereditary spastic paraplegia 4 (8)
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
SPAST-related disorder (1)
-
-
-
Cerebral palsy (1)
-
-
-
SPASTIC PARAPLEGIA 4, MODIFIER OF (1)

Computational Scores

AlphaGenome AVI
Pathogenic22
AlphaMissense
Benign0.20
BayesDel_addAF
Uncertain0.023T
BayesDel_noAF
Pathogenic0.27
CADD
Uncertain25
DANN
Uncertain0.98
DEOGEN2
Benign0.40T
Eigen
Benign-0.52
Eigen_PC
Benign-0.42
FATHMM_MKL
Uncertain0.80D
GPN-Star LLR
N/A-5.2
GPN-Star score
N/A5.2
LIST_S2
Uncertain0.87D
M_CAP
Pathogenic0.91D
MetaRNN
Benign0.011T
MetaSVM
Uncertain0.14D
Mutation Taster
N/A88/12polymorphism
MutationAssessor
Benign0.55N
PhyloP100
Uncertain5.1
popEVE
Benign-3.2
PrimateAI
Pathogenic0.82D
PromoterAI
N/A-0.058Neutral
PROVEAN
Benign-1.8N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.1
REVEL
Uncertain0.53
Sift
Uncertain0.0020D
Sift4G
Uncertain0.0030D
Varity_R
N/A0.15
VESM-3B
Benign-3.7
Showing 30 of 30 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs121908515;
hg19: chr2-32289031;
COSMIC: COSV99043708;
COSMIC: COSV99043708;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.